Mianserin EP Impurity A | CAS 57321-32-1 - Request Quote
Mianserin EP Impurity A
| SZ CAT No: | SZ-M087002 |
| CAS No | 57321-32-1 |
| Mol.F. | C18H22N2O |
| Mol.Wt. | 282.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mianserin EP Impurity A is chemically [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]phenyl]methanol (as per EP). Mianserin EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Mianserin EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mianserin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 57321-32-1
Purchase 57321-32-1
Order 57321-32-1
Enquire 57321-32-1
price of 57321-32-1
57321-32-1 Supplier
57321-32-1 Manufacturer
57321-32-1 Exporter
buy high quality Mianserin EP Impurity A
Purchase Mianserin EP Impurity A
Mianserin EP Impurity A suppliers
Mianserin EP Impurity A manufacturers
Mianserin EP Impurity A price
Order Mianserin EP Impurity A
Enquire Mianserin EP Impurity A
Mianserin EP Impurity A cost
Mianserin EP Impurity A Supplier
Mianserin EP Impurity A Distributor
Mianserin EP Impurity A for Method Validation
Mianserin Reference Standard
Mianserin EP Impurity A for ANDA Filing
Mianserin EP Impurity A for Forced Degradation Studies
Mianserin EP Impurity A Identification Standards
Mianserin EP Impurity A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.